Brind.

Thierry orchestrated the acquisition of Amolyt Pharma by AstraZeneca and the acquisition of his venture Alizé Pharma 2 by Jazz Pharmaceuticals.

1 report, 0 independent Updated Jul 7

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

AstraZeneca Jazz Pharmaceuticals

Keep exploring

The entities involved

AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52
Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
- Jazz Pharmaceuticals plans U.S. launch of Ziihera.Wed 22:28
- Alan M. Sebulsky was appointed to the Board of Directors of MeiraGTx Holdings PLC, where he has previously served.Wed 13:55

Coverage

Newest first; wire copies grouped

Jul 7Unknown outlet